Challenges and Opportunities of mRNA Vaccines Against SARS-CoV-2: A Multidisciplinary Perspective
Autor Siguna Muelleren Limba Engleză Paperback – 7 ian 2024
This book offers an analytical look at the much debated risks and benefits of the newly developed COVID-19 mRNA-vaccines. As such, it is one of the first books to give a comprehensive overview of mRNA vaccines against COVID-19 and the only one that addresses this topic from a broad multidisciplinary background. It brings together insights from various underlying disciplines on the challenges of developing and evaluating the most suitable vaccines for mass vaccination programs enrolled throughout the world - focusing on safety and efficacy.
This book should not be missing on the shelf of any biomedical researcher, epidemiologist, public health professional or clinical researcher interested in SARS-CoV2 or virology and vaccine development in general.
| Toate formatele și edițiile | Preț | Express |
|---|---|---|
| Paperback (1) | 880.06 lei 6-8 săpt. | |
| Springer International Publishing – 7 ian 2024 | 880.06 lei 6-8 săpt. | |
| Hardback (1) | 886.27 lei 6-8 săpt. | |
| Springer International Publishing – 6 ian 2023 | 886.27 lei 6-8 săpt. |
Preț: 880.06 lei
Preț vechi: 1073.25 lei
-18% Nou
Puncte Express: 1320
Preț estimativ în valută:
168.41€ • 177.17$ • 139.79£
168.41€ • 177.17$ • 139.79£
Carte tipărită la comandă
Livrare economică 15-29 ianuarie 25
Preluare comenzi: 021 569.72.76
Specificații
ISBN-13: 9783031189050
ISBN-10: 3031189051
Pagini: 439
Ilustrații: XXXII, 439 p. 61 illus., 60 illus. in color.
Dimensiuni: 155 x 235 mm
Greutate: 0.65 kg
Ediția:1st ed. 2023
Editura: Springer International Publishing
Colecția Springer
Locul publicării:Cham, Switzerland
ISBN-10: 3031189051
Pagini: 439
Ilustrații: XXXII, 439 p. 61 illus., 60 illus. in color.
Dimensiuni: 155 x 235 mm
Greutate: 0.65 kg
Ediția:1st ed. 2023
Editura: Springer International Publishing
Colecția Springer
Locul publicării:Cham, Switzerland
Cuprins
Chapter 1: Introduction.- Part I: Scientifi Underpinnings, early expectations, and emerging challenges from the global inoculation experience.- Chapter 2: Appraisal of Some of the Key Postulates Underlying mRNA Vaccines.- Chapter 3: Relevance for mRNA vaccine safety.- Chapter 4: From Challenges to Opportunities and Open Questions.- Chapter 5: The challenge of evaluating vaccine safety and effectiveness.- Chapter 6: Safeguarding against the analog of antimicrobial-resistance development.- Chapter 7: Scales, pseudoscales, the human factor, and a way forward.- Part II: A deeper dive into mRNA vaccine safety and security, and developments until Delta.- Chapter 8: mRNA Vaccine safety and efficacy - official criteria when AEs are caused by the injection.- Chapter 9: mRNA Covid-19 vaccines best reflect effective pharmaceuticals - basic considerations and LNPs.- Chapter 10: mRNA Covid-19 pharmaceuticals and the spike antigen.- Chapter 11: Other facets of SARS-CoV-2 immunity, the risk of immune tolerance and T cell exhaustion.- Part III: The Omicron variants.- Chapter 12: Omicron.- Chapter 13: Conclusion.
Notă biografică
Siguna Mueller spent the first 20 years of her academic career in mathematics (M.S. in Mathematics and Statistics and Ph.D. in Mathematics, University of Klagenfurt, Austria, both summa cum laude). She was among the first women in Austria to receive the Habilitation in Discrete Mathematics and Cryptography (2002). The following 15 years she spent as a Research Associate at the Centre for Information Security and Cryptography Research, University of Calgary, and as an Assistant Professor at the University of Wyoming. A lifelong passion for biology and medicine eventually triggered her decision to radically expand her field of expertise. Consequently, she earned her second Ph.D. (Biomedical Sciences) in 2014 at the University of Wyoming (with a GPA of 4.0). Since then she has been utilizing her experience in the theoretical fields to help advance a broader appreciation and comprehension of phenomena and challenges arising in the biological and life science domains. For almost ten years, she has been warning of new Biosafety and Public Health dangers, but for years was ignored. Only recently, her concerns about new safety/security challenges in synthetic biology have been supported by others, and she has become one of the leaders in the new field of cyberbiosecurity. Her interests and curiosities are not limited to the above-mentioned disciplines as she finds great excitement in physics, theology, philosophy, ethics, spirituality, and the complexity and fascination of nature altogether. As such, it has been natural for her, employing her multi-disciplinary experience, to appraise the new Covid-19 vaccines, through rigorous, balanced, and scientific logic.
Textul de pe ultima copertă
This book offers an analytical look at the much debated risks and benefits of the newly developed COVID-19 mRNA-vaccines. As such, it is one of the first books to give a comprehensive overview of mRNA vaccines against COVID-19 and the only one that addresses this topic from a broad multidisciplinary background. It brings together insights from various underlying disciplines on the challenges of developing and evaluating the most suitable vaccines for mass vaccination programs enrolled throughout the world - focusing on safety and efficacy.
This book should not be missing on the shelf of any biomedical researcher, epidemiologist, public health professional or clinical researcher interested in SARS-CoV2 or virology and vaccine development in general.
Caracteristici
Analyzes the the risks and benefits of mass vaccination with mRNA vaccines Covers the most recent scientific data on Covid-19 mRNA vaccines Offers a broad multidisciplinary look at mRNA vaccines